PFS
STML

Prospera Financial Services’s Stemline Therapeutics, Inc. STML Stock Holding History

Prospera Financial Services’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,100
Closed -$102K – 611
2020
Q1 		$102K Buy
21,100
+8,735
+71% +$56.6K 0.01% 495
2019
Q4 		$131K Buy
+12,365
New +$123K 0.01% 581

Prospera Financial Services's STML Position: Q2 2020 in Review

Prospera Financial Services sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 21,100 shares — an estimated $102K sold.

Prospera Financial Services first reported a position in STML in Q4 2019 and held it in 2 quarters. The position peaked at $131K in Q4 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Prospera Financial Services reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Prospera Financial Services sold 21,100 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $102K.
  • Prospera Financial Services first reported a position in Stemline Therapeutics, Inc. in Q4 2019 and held it in 2 quarters.
  • Prospera Financial Services's Stemline Therapeutics, Inc. position peaked at $131K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Prospera Financial Services's 13F filing for Q2 2020, filed 7 Aug 2020.